ArticleInternational journal of general medicine2025
The Value of Myocardial Energy Expenditure in the Diagnosis of Cirrhotic Cardiomyopathy.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the diagnostic value of myocardial energy expenditure (MEE) in cirrhotic cardiomyopathy (CCM). Methods: A cohort of 100 patients with cirrhosis were classified into a CCM group (34 cases) and a non-CMM group (66 cases) based on the 2020 CCM guidelines. Moreover, 30 healthy volunteers served as a control group. MEE and conventional echocardiographic parameters were measured, and intergroup differences were analyzed. MEE was measured by ultrasound and calculated by formula. Multivariate logistic regression was performed to determine the relationship between significant indicators and CCM. Receiver operating characteristic (ROC) curve analysis was conducted to assess the diagnostic performance of MEE, echocardiographic parameters, and their combination (MEE + echocardiography) in diagnosing CCM. Results: (1) Significant differences were observed in the left atrial volume index (LAVI), left ventricular ejection fraction (LVEF), Tei index(TI), early/late peak diastolic flow rate (E/A) ratio, and MEE among the three groups ( Conclusion: MEE and LVEF are reliable predictive markers for CCM, with their combined assessment offering superior diagnostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.